Affluent Medical Achieves Clinical Objective with Artus Device

Affluent Medical has reached a significant milestone in the clinical development of its Artus artificial urinary sphincter. The company successfully implanted the innovative device in a second patient in Krakow, Poland. Following this, both initial patients had their devices activated six weeks after surgery with no reported discomfort.

The Artus device is designed to treat urinary incontinence in both men and women, a condition affecting 400 million people globally. The recent surgery in Poland, performed by Professor Piotr Chlosta, took only 45 minutes. This minimally invasive procedure demonstrated the ease of device preparation and implantation.

A performance assessment is scheduled for three months post-activation to evaluate the reduction in urinary leakage. This development is a part of the broader European pilot study named “Dry.” Affluent Medical aims to include ten patients in the study by the end of 2024.

Urinary incontinence, a widespread public health concern, significantly impacts social life and mental health. The global market for urinary incontinence treatments is expected to grow significantly, reaching $4.3 billion by 2027.